Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT02111096

Public ClinicalTrials.gov record NCT02111096. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 3:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects With Type 2 Diabetes Mellitus

Study identification

NCT ID
NCT02111096
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
174 participants

Conditions and interventions

Interventions

  • LY2409021 Drug
  • Metformin Drug
  • Placebo Drug
  • Sitagliptin Drug
  • Sulfonylurea Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 79 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2014
Primary completion
Aug 31, 2015
Completion
Aug 31, 2015
Last update posted
Oct 8, 2019

2014 – 2015

United States locations

U.S. sites
26
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
John Muir Health Network - The Osteoporosis Center Concord California 94520
Valley Endocrine, Fresno Fresno California 93720
National Research Institute Los Angeles California 90057
Suncoast Research Group, LLC Miami Florida 33135
New Horizon Research Center Miami Florida 33175
Clinical Research of West Florida, Inc. Tampa Florida 33603
University of Hawaii Honolulu Hawaii 96813
East West Medical Institute Honolulu Hawaii 96814
Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls Idaho 83404
Cedar-Crosse Research Center Chicago Illinois 60607
Midwest CRC Crystal Lake Illinois 60012
Iderc, P.L.C. Des Moines Iowa 50314
Cotton O'Neil Clinic Topeka Kansas 66606
Centex Studies, Inc Lake Charles Louisiana 70601
Cosmopolitan International Diabetes Center Columbia Missouri 65212
Mercy Medical Research Institute Springfield Missouri 65807
Palm Research Center Las Vegas Nevada 89148
SHS Clinical Research Group Toms River New Jersey 08753
Office:Alwine,Lk Downingtown Pennsylvania 19335
University Diabetes and Endocrine Consultants Chattanooga Tennessee 37411
Dallas Diabetes Endocrine Center Dallas Texas 75230
Galenos Research Dallas Texas 75251
San Gabriel Clinical Research Georgetown Texas 78626
Oakwell Clinical Research San Antonio Texas 78218
Victorium Clinical Research San Antonio Texas 78240
Polyclinic Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02111096, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2019 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02111096 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →